Vladimir Ioffe
MD
Radiation Oncologist
Languages spoken
English, Russian
Expert in
Stereotactic Radiosurgery (CyberKnife) and Brachytherapy
Overview
Centers
Specializes in
Treatments
Vladimir Ioffe, MD is a board certified radiation oncologist with experience treating a wide variety of cancers in the Baltimore-Washington region. He has worked in both academic as well as private practice settings. He has special training in Stereotactic Radiosurgery (CyberKnife) and Brachytherapy. He has a special interest in prostate brachytherapy and maintains a high volume program in both High-Dose Rate (HDR) and Low-Dose Rate (LDR) prostate brachytherapy. Dr. Ioffe uses the latest technology (IMRT and IGRT) for patient treatments including the TomoTherapy linear accelerator which optimizes care for a variety of cancers.
.svg){kind=icon}
Career Positions
Current position(s)
- GenesisCare - Radiation Oncologist, Bel Air, MD and Greenbelt, MD
Past position(s)
- Fox Chase Cancer Center - Assistant Professor, Radiation Oncology, Philadelphia, PA
- Pinnacle Health, Fox Chase Regional Cancer Center - Radiation Oncologist, Harrisburg, PA
Education
Universities
- University of Maryland Baltimore County, BS, Biochemistry & Molecular Biology, Baltimore, MD
- University of Maryland School of Medicine, Baltimore, MD
Residencies
- Eastern Virginia School of Medicine, Norfolk General Hospital, Radiation Oncology, Chief Resident, Norfolk, VA
- University of Texas, Southwestern Medical Center, Clinical Externship, Stereotactic Body Radiation Therapy, Dallas, TX
Internships
- University of Maryland Medical Center, Internal Medicine, Baltimore, MD
Expertise And Interests
Interests
- Prostate, Breast, Lung, Colorectal, Head and Neck, Thyroid, Thoracic Malignancies
Professional associations
Accomplishments
Awards and honors
- Magna cum laude at University of Maryland
- Rhodes Scholar Finalist
- RSNA Resident Research Trainee Prize
- American College of Physicians 2nd Place Poster Competition
- AMA Foundation Leadership Award for Public Health Advocacy
Publications
- Lifesaving ‘justice’ in a vial of blood
- Prostate biopsy characteristics: A comparison between pre- and post- United States Preventive Service Task Force Prostate Cancer Screening Guidelines of 2012
- Frequency of Gleason Score 7 to 10 in 5100 Elderly Prostate Cancer Patients
- Increasing aggressive prostate cancer View publication
- Prostate Biopsy Features: A Comparison Between the Pre– and Post–2012 United States Preventive Services Task Force Prostate Cancer Screening Guidelines With Emphasis on African American and Septuagenarian Men
- Prostate biopsy characteristics: A comparison between pre- and post- United States Preventive Service Task Force Prostate Cancer Screening Guidelines of 2012